113 related articles for article (PubMed ID: 1322328)
1. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats.
Young AA; Carlo P; Rink TJ; Wang MW
Mol Cell Endocrinol; 1992 Mar; 84(1-2):R1-5. PubMed ID: 1322328
[TBL] [Abstract][Full Text] [Related]
2. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
[TBL] [Abstract][Full Text] [Related]
3. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo.
Wang MW; Young AA; Rink TJ; Cooper GJ
FEBS Lett; 1991 Oct; 291(2):195-8. PubMed ID: 1936264
[TBL] [Abstract][Full Text] [Related]
4. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
[TBL] [Abstract][Full Text] [Related]
5. Dose-response for glucagonostatic effect of amylin in rats.
Gedulin BR; Rink TJ; Young AA
Metabolism; 1997 Jan; 46(1):67-70. PubMed ID: 9005972
[TBL] [Abstract][Full Text] [Related]
6. Effects of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide (CGRP) on glucose metabolism in the rat.
Morishita T; Yamaguchi A; Yamatani T; Nakamura A; Arima N; Yamashita Y; Nakata H; Fujita T; Chiba T
Diabetes Res Clin Pract; 1992 Jan; 15(1):63-9. PubMed ID: 1541237
[TBL] [Abstract][Full Text] [Related]
7. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
[TBL] [Abstract][Full Text] [Related]
8. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
Young AA; Rink TJ; Wang MW
Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
[TBL] [Abstract][Full Text] [Related]
9. Amylin and amylin-amide lack an acute effect on blood glucose and insulin.
Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR
J Endocrinol; 1990 Feb; 124(2):R9-11. PubMed ID: 2179452
[TBL] [Abstract][Full Text] [Related]
10. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats.
Gedulin BR; Young AA
Diabetes; 1998 Jan; 47(1):93-7. PubMed ID: 9421380
[TBL] [Abstract][Full Text] [Related]
12. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.
Beaumont K; Moore CX; Pittner RA; Prickett KS; Gaeta LS; Rink TJ; Young AA
Can J Physiol Pharmacol; 1995 Jul; 73(7):1025-9. PubMed ID: 8846395
[TBL] [Abstract][Full Text] [Related]
13. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.
Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR
Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050
[TBL] [Abstract][Full Text] [Related]
14. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.
Ye JM; Lim-Fraser M; Cooney GJ; Cooper GJ; Iglesias MA; Watson DG; Choong B; Kraegen EW
Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E562-9. PubMed ID: 11254462
[TBL] [Abstract][Full Text] [Related]
15. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin.
Young AA; Gedulin B; Gaeta LS; Prickett KS; Beaumont K; Larson E; Rink TJ
FEBS Lett; 1994 May; 343(3):237-41. PubMed ID: 8174707
[TBL] [Abstract][Full Text] [Related]
16. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.
Pieber TR; Roitelman J; Lee Y; Luskey KL; Stein DT
Am J Physiol; 1994 Jul; 267(1 Pt 1):E156-64. PubMed ID: 8048505
[TBL] [Abstract][Full Text] [Related]
17. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
Haynes JM; Hodgson WC; Cooper ME
Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
[TBL] [Abstract][Full Text] [Related]
18. Amylin, a peptide expressed by nociceptors, modulates chronic neuropathic pain.
Almeida LS; Castro-Lopes JM; Neto FL; Potes CS
Eur J Pain; 2019 Apr; 23(4):784-799. PubMed ID: 30506955
[TBL] [Abstract][Full Text] [Related]
19. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.
Molina JM; Cooper GJ; Leighton B; Olefsky JM
Diabetes; 1990 Feb; 39(2):260-5. PubMed ID: 2227135
[TBL] [Abstract][Full Text] [Related]
20. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
